Kadmon

Kadmon

Kadmon

Kadmon Corporation is a biopharmaceutical company offering products and servicesfor the treatment and management of hepatitis C.
Type
B2b
Founded
2009
Raised
$109.1M
Follow us
Alexa global traffic share
Latest funding Show all
$23,000,000
Post-IPO equity - 2017
Team Size
50+
Employees
MedCity News

Sanofi scoops up Kadmon and its newly approved drug in a $1.9B deal

$23,000,000 Post-IPO equity
businesswire

Kadmon Announces Approximately $23 Million Equity Financing

Xconomy

Kadmon Seeks IPO With Unusual Terms That Benefit Waksal, Debt Holders

Stock markets Strategy